OA-46 Phase II Clinical Trial of Minimal Residual Disease Response-Adapted Deferral of Transplantation in Dysproteinemia (MILESTONE)
Authors:
- Susan BalSBSusan Bal
- Smit GiriSGSmit Giri
- Gayathri RaviGRGayathri Ravi
- Kelly GodbyKGKelly Godby
- Caitlin HagedornCHCaitlin Hagedorn
- Laura JoinerLJLaura Joiner
- Frances LundFLFrances Lund
- Luciano CostaLCLuciano Costa
- 24 September 2024
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 24, S29